Gene therapy delivery is the medical technology used to carry helpful genetic instructions into a patient's cells. These instructions may replace a missing gene, silence a harmful gene, or help cells make a therapeutic protein. Delivery matters because DNA and RNA are large, fragile molecules that cannot easily cross the cell membrane on their own.
A successful treatment depends on getting the right genetic cargo into the right cells at the right dose.
Key Facts
- Gene therapy delivery moves DNA or RNA into target cells so they can produce, edit, or regulate specific proteins.
- Viral vectors use modified viruses to enter cells while removing or disabling disease-causing viral genes.
- Non-viral carriers include lipid nanoparticles, polymers, and physical methods such as electroporation.
- Transduction efficiency = successfully modified cells / total target cells.
- Dose per cell can be estimated as vector particles per cell = total vector particles / number of target cells.
- Therapeutic effect depends on delivery to the correct tissue, cellular uptake, gene expression, and immune safety.
Vocabulary
- Gene therapy
- A treatment approach that adds, replaces, edits, or silences genetic material to treat disease.
- Vector
- A carrier that transports therapeutic DNA or RNA into a target cell.
- Viral vector
- A modified virus used to deliver genetic cargo into cells without causing the original viral disease.
- Lipid nanoparticle
- A tiny fat-based particle that can protect RNA or DNA and help it cross cell membranes.
- Transduction
- The process by which a viral vector delivers genetic material into a cell.
Common Mistakes to Avoid
- Assuming the therapeutic gene automatically reaches every cell. Delivery is limited by tissue access, dose, immune clearance, and whether the vector can bind to the target cells.
- Treating all vectors as the same. Viral vectors, lipid nanoparticles, and polymer carriers differ in cargo size, immune response, cell targeting, and how long gene expression lasts.
- Confusing gene delivery with gene editing. Delivery only describes moving genetic material into cells, while editing changes a DNA sequence using tools such as CRISPR.
- Ignoring the nucleus as a barrier. Some therapies must reach the nucleus to work, while many RNA therapies act in the cytoplasm and do not need nuclear entry.
Practice Questions
- 1 A treatment dose contains 2.0 x 10^11 vector particles and is aimed at 5.0 x 10^7 target cells. Calculate the average number of vector particles available per target cell.
- 2 In a lab test, 12,000 out of 50,000 cells express a delivered therapeutic gene. Calculate the transduction efficiency as a percent.
- 3 A viral vector enters target cells efficiently but causes a strong immune reaction after injection. Explain why high delivery efficiency alone is not enough for a safe gene therapy.